Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

By LabMedica International staff writers
Posted on 22 May 2025

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. More...

This group is at an elevated risk for respiratory distress, a major contributor to neonatal morbidity and prolonged hospitalizations. Conventional clinical approaches often rely on a "wait and see" method to determine which infants require intervention. Unfortunately, this approach can lead to higher NICU admissions, delayed treatments, increased healthcare expenses, and added stress for families and infants. Now, an artificial intelligence (AI)-driven lung maturity test (LMT) is poised to close this gap by providing an objective screening tool to help identify newborns who are at risk more promptly.

SIME Diagnostics (London, UK) has developed an innovative platform that includes a point-of-care device and a single-use cartridge designed to quickly analyze routinely collected samples without the need for reagents. The device enables the real-time evaluation of lung biochemistry by measuring key biomarkers—lecithin and sphingomyelin. These biomarkers' ratio reflects surfactant levels, which are crucial for efficient oxygen exchange in developing lungs. By offering clinicians valuable data to guide respiratory support decisions within the first hour of life, the AI platform aids in the early identification of infants needing intervention, reducing unnecessary treatments and minimizing delays. This platform is specifically designed for use in intensive care settings, helping healthcare professionals provide timely and focused respiratory care.

In a recent study involving 207 late-preterm infants (those born at more than 30 weeks' gestation), researchers tested gastric aspirate samples using the point-of-care device from SIME Diagnostics. The results indicated that the LMT successfully assessed biomarkers related to lung maturity, facilitating early identification of infants at risk for respiratory distress. The study concluded that the device accurately predicted which infants would require extended respiratory support and identified those whose need for such support would resolve within six hours. Ongoing studies and clinical assessments aim to refine the device's applications further, potentially extending its use across various hospital settings.

Related Links:
SIME Diagnostics


New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
Blood Glucose Test Strip
AutoSense Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: The partnership between OGT and QIAGEN unlocks a complete sample to report workflow for SureSeq NGS panels (Photo courtesy of OGT)

Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation

In clinical research, next-generation sequencing (NGS) panels provide essential insights for genetic analysis, but many laboratories face challenges in transforming raw sequencing data into clinically... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.